Spain is moving forward with a framework for medical cannabis usage after delays due to a general election. The draft ...

Trevi Therapeutics has achieved key milestones in its clinical programs for Haduvio (nalbuphine), a treatment targeting ...

Singapore’s Agency for Science, Technology and Research (A*STAR) and US biotech incubator Flagship Pioneering have agree to ...

GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the ...

NHS England has proposed a phased rollout of Eli Lilly’s obesity injection Mounjaro (tirzepatide), prioritizing patients with ...

Kurma Partners has raised €140 million ($154 million) in the first closing of its Biofund IV, with a target of €250 million ...

Opioid Use Disorder (OUD) is a chronic neurological disorder that is described as the consequences associated with repeated, ...

Bristol Myers Squibb has received FDA approval for Opdivo (nivolumab) combined with chemotherapy as a perioperative treatment ...

Sirnaomics has entered a subscription agreement with biotech specialist Poon Hung Fai, who will acquire over 17.5 million ...

The European Medicines Agency’s pharmacovigilance committee, PRAC, has started a review of medicines containing finasteride ...

Aspire Pharma, a UK-based niche generics firm, has acquired all assets from Canute Pharma, expanding its product range and ...

The US Food and Drug Administration (FDA) has removed the partial clinical hold on delpacibart etedesiran (del-desiran/AOC ...